Is Unisom Addictive? OTC Sleep Aid Dependence and Better Alternatives

Is Unisom addictive? Not in the clinical sense of addiction, but dependence on it is common and underrecognized. Unisom comes in two formulas: SleepTabs contain doxylamine succinate, and SleepGels contain diphenhydramine. Both are antihistamines that produce sedation by blocking histamine H1 receptors. Daily use builds tolerance within 1 to 2 weeks. Stopping triggers rebound insomnia that keeps people reaching for the next pill.

Over-the-counter sleep aids generated $1.7 billion in US sales in 2024. Many buyers take them nightly for months or years without realizing they are trapped in a rebound cycle. No medical guideline recommends antihistamines for long-term insomnia treatment.

Key Facts About Unisom Dependence

Unisom SleepTabs contain doxylamine succinate (25 mg per tablet).
Unisom SleepGels contain diphenhydramine (50 mg per capsule), the same ingredient as Benadryl and ZzzQuil.
Tolerance to sedation develops within 3 to 7 days of daily use.
Rebound insomnia after stopping is the primary driver of continued use.
Long-term antihistamine use is linked to cognitive decline and increased dementia risk in older adults.

How Unisom Dependence Develops

The cycle follows a predictable pattern. You have trouble sleeping, so you take a Unisom tablet. It works. You take one the next night. And the next. Within a week, the same dose is less effective. Your brain has upregulated histamine receptors to compensate for the nightly blockade.

When you skip a night, those sensitized histamine receptors flood with activity. You are more awake than you were before you started taking Unisom. This rebound insomnia is worse than the original sleep problem and convinces you that you cannot sleep without the pill. The cycle is self-reinforcing.

Doxylamine vs Diphenhydramine

Both antihistamines produce similar dependence patterns, but doxylamine (Unisom SleepTabs) has a longer half-life (10 hours vs 4 to 8 hours for diphenhydramine). This means more morning grogginess and a potentially smoother but longer withdrawal adjustment period.

The American Academy of Sleep Medicine’s 2017 clinical practice guideline stated: “We suggest that clinicians not use antihistamines as a treatment for sleep onset or sleep maintenance insomnia in adults.” This recommendation was based on “very low quality evidence for efficacy and the potential for significant adverse effects.”

Health Risks of Long-Term OTC Sleep Aid Use

Cognitive impairment: Anticholinergic drugs impair memory and processing speed. A 2019 JAMA Internal Medicine study linked cumulative anticholinergic use to 50% higher dementia risk.
Next-day impairment: Driving and work performance suffer due to residual sedation.
Dry mouth: Increases risk of cavities and gum disease.
Constipation and urinary retention: Anticholinergic effects on smooth muscle.
Fall risk: Particularly concerning for adults over 65.

How to Stop Unisom Safely

A gradual taper minimizes rebound insomnia. Reduce your dose over 1 to 2 weeks:

If taking 50 mg diphenhydramine: cut to 25 mg for 5 nights, then stop.
If taking 25 mg doxylamine: cut to 12.5 mg (half a tablet) for 5 nights, then stop.
Expect 3 to 7 nights of worse sleep after stopping. This is temporary.

The rebound period is uncomfortable but not dangerous. Melatonin (0.5 to 3 mg) taken 30 minutes before bed can help during the transition.

Better Alternatives for Chronic Insomnia

CBT for insomnia (CBT-I) is recommended as first-line treatment by every major sleep medicine organization. It addresses the behaviors and thoughts that maintain insomnia without medication side effects. CBT-I is available through therapists, online programs (Somryst, an FDA-cleared digital therapeutic), and some primary care practices.

If you have been using Unisom nightly for weeks or months, talk to your doctor about transitioning to evidence-based insomnia treatment. If sleep problems are related to anxiety, depression, or substance use, SAMHSA (1-800-662-4357) can help connect you to appropriate care.